A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy

A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy

Shuheng Zhang, Yuanyuan Zhang, Wanyu Wang, Yuzhu Hu, Xinchuan Chen, Bilan Wang, Xiang Gao

PDF(5955 KB)

　

Search
Submit
E-mail
RSS

Chinese Chemical Letters ›› 2024, Vol. 35 ›› Issue (12) : 109658. DOI: 10.1016/j.cclet.2024.109658

A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 35(12): 109658 https://doi.org/10.1016/j.cclet.2024.109658

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(5955 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉